.. Brookhaven Research Associates, BioSET receive U.S. Patent for cells regeneration technology Second-generation technology offers multiple applications in soft cells repairBrookhaven Science Associates, the ongoing company that manages the U.S. Department of Energy’s Brookhaven National Laboratory, and Biosurface Engineering Technologies, Inc. of Rockville, Maryland, have already been released a U.S. Patent for a better second-generation technology for designing artificial peptides that are important for cells regeneration. These bioactive peptides are created to communicate growth indicators to cells of broken tissue to be able to foster efficient, quick healing. BioSET has an exclusive permit for making these peptides, which hold guarantee for improving your body’s healing response in various applications of tissue fix.Related StoriesBrain wellness: how can you reduce cognitive decline? An interview with Heather Snyder, Ph.D.Deaths from avoidable risk factors: an interview with Dr Ali Mokdad, IHMEStanford researchers identify a progenitor cell type that could fix damaged arteriesThe procedure is also expensive. Due to the related costs of angiograms, including the need for special tools and trained employees, the procedure is currently conducted in Alberta in only two cities: Edmonton and Calgary .